Zenshine Pharma and Cigalah Medpharm Trading LLC Forge Strategic Partnership, Bringing Sebaloxavir Marboxil to the MENA Market
NMPA Approves Sebaloxavir Marboxil Tablets for the Treatment of Uncomplicated Influenza in Adults
NDA filing accepted by NMPA for Seloxavir Marboxil of Zenshine pharma’s Class 1 New Drug
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults
